The wearable and IoMT medical devices market size has grown rapidly in recent years. It will grow from $13.92 billion in 2025 to $15.84 billion in 2026 at a compound annual growth rate (CAGR) of 13.8%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, growth in wearable technology adoption, increasing healthcare digitization, expansion of telemedicine services, advancements in sensor technologies.
The wearable and IoMT medical devices market size is expected to see rapid growth in the next few years. It will grow to $26.8 billion by 2030 at a compound annual growth rate (CAGR) of 14.1%. The growth in the forecast period can be attributed to increasing demand for personalized healthcare solutions, rising adoption of remote patient monitoring systems, growing investment in digital health platforms, expansion of aging population healthcare needs, increasing focus on preventive healthcare. Major trends in the forecast period include increasing adoption of remote patient monitoring devices, growing demand for continuous real-time health tracking, rising integration of multi-parameter sensing in wearable devices, expansion of home-based healthcare solutions, development of compact and energy-efficient wearable medical devices.
The rising prevalence of chronic diseases is expected to drive the growth of the wearable and IoMT medical devices market going forward. Chronic diseases refer to long-term health conditions such as diabetes, cardiovascular diseases, and respiratory disorders that require continuous monitoring and long-term care management. The increase in chronic diseases is primarily driven by aging populations and prolonged exposure to lifestyle risk factors in developed economies. Wearable and IoMT medical devices support this trend by enabling real-time health tracking, remote patient monitoring, and early disease detection through connected sensors and smart medical technologies. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000 in 2024, up 4% from 224.4 per 100,000 in 2023. Therefore, the rising prevalence of chronic diseases is driving the growth of the wearable and IoMT medical devices market.
Leading companies operating in the wearable and IoMT medical devices market are focusing on integrated artificial intelligence health monitoring systems, such as AI-assisted on-device health data access software and sensors that collect and interpret user health metrics in real time to support personalized wellness insights and medical reporting to gain a competitive advantage. AI-assisted on-device health data access enables wearables to combine multi-sensor inputs with machine-learning models to deliver actionable health insights and track trends over time with minimal user intervention. For example, in September 2023, Apple Inc., a US-based consumer electronics and wearable technology company, introduced the Apple Watch Series 9, featuring the custom S9 SiP with on-device Siri capable of accessing and logging health data securely, enhanced machine-learning-driven sensor fusion for more responsive health tracking, and expanded metrics support through watchOS 10. These capabilities strengthen continuous monitoring and user engagement, though regulatory validation and clinical acceptance for some metrics remain evolving.
In January 2025, ActiGraph LLC, a US-based digital health technology company, acquired the life sciences division of Biofourmis for an undisclosed value. Through this acquisition, the objective is to broaden capabilities in AI-enabled remote patient monitoring along with wearable-integrated health data analytics, thereby improving clinical trial optimization and enabling real-time patient insights. Biofourmis is a US-based digital therapeutics company that offers AI-driven health analytics, remote patient monitoring, and wearable-integrated care solutions.
Major companies operating in the wearable and iomt medical devices market are Apple Inc., Samsung Electronics Co. Ltd., Huawei Technologies Co. Ltd., Abbott Laboratories, Xiaomi Corporation, Medtronic plc, Siemens Healthineers AG, Philips Healthcare, GE HealthCare Technologies Inc., Boston Scientific Corporation, Omron Healthcare Co. Ltd., Garmin Ltd., ResMed Inc., Dexcom Inc., Masimo Corporation, BIOTRONIK SE & Co. KG, iRhythm Technologies Inc., BioIntelliSense Inc., Valencell Inc., LifeSignals Inc., VitalConnect Inc., Intelesens Ltd., Sempulse Private Limited, Biobeat Technologies Ltd.
North America was the dominating region in the wearable and IoMT medical market in 2025. Asia-Pacific is expected to be the rapidly expanding region during the forecast period. The regions covered in the wearable and IoMT medical devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the wearable and IoMT medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The wearable and IoMT medical devices market consists of revenues earned by entities by providing services such as remote patient monitoring, real-time health data collection and analysis, device connectivity and integration, and digital health management through connected wearable and internet-enabled medical devices. The market value includes the value of related goods sold by the service provider or included within the service offering. The wearable and IoMT medical devices market also includes sales of wearable health monitoring devices, internet-enabled medical devices, connected biosensors, and smart diagnostic and monitoring equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The wearable and IoMT medical devices market size is expected to see rapid growth in the next few years. It will grow to $26.8 billion by 2030 at a compound annual growth rate (CAGR) of 14.1%. The growth in the forecast period can be attributed to increasing demand for personalized healthcare solutions, rising adoption of remote patient monitoring systems, growing investment in digital health platforms, expansion of aging population healthcare needs, increasing focus on preventive healthcare. Major trends in the forecast period include increasing adoption of remote patient monitoring devices, growing demand for continuous real-time health tracking, rising integration of multi-parameter sensing in wearable devices, expansion of home-based healthcare solutions, development of compact and energy-efficient wearable medical devices.
The rising prevalence of chronic diseases is expected to drive the growth of the wearable and IoMT medical devices market going forward. Chronic diseases refer to long-term health conditions such as diabetes, cardiovascular diseases, and respiratory disorders that require continuous monitoring and long-term care management. The increase in chronic diseases is primarily driven by aging populations and prolonged exposure to lifestyle risk factors in developed economies. Wearable and IoMT medical devices support this trend by enabling real-time health tracking, remote patient monitoring, and early disease detection through connected sensors and smart medical technologies. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000 in 2024, up 4% from 224.4 per 100,000 in 2023. Therefore, the rising prevalence of chronic diseases is driving the growth of the wearable and IoMT medical devices market.
Leading companies operating in the wearable and IoMT medical devices market are focusing on integrated artificial intelligence health monitoring systems, such as AI-assisted on-device health data access software and sensors that collect and interpret user health metrics in real time to support personalized wellness insights and medical reporting to gain a competitive advantage. AI-assisted on-device health data access enables wearables to combine multi-sensor inputs with machine-learning models to deliver actionable health insights and track trends over time with minimal user intervention. For example, in September 2023, Apple Inc., a US-based consumer electronics and wearable technology company, introduced the Apple Watch Series 9, featuring the custom S9 SiP with on-device Siri capable of accessing and logging health data securely, enhanced machine-learning-driven sensor fusion for more responsive health tracking, and expanded metrics support through watchOS 10. These capabilities strengthen continuous monitoring and user engagement, though regulatory validation and clinical acceptance for some metrics remain evolving.
In January 2025, ActiGraph LLC, a US-based digital health technology company, acquired the life sciences division of Biofourmis for an undisclosed value. Through this acquisition, the objective is to broaden capabilities in AI-enabled remote patient monitoring along with wearable-integrated health data analytics, thereby improving clinical trial optimization and enabling real-time patient insights. Biofourmis is a US-based digital therapeutics company that offers AI-driven health analytics, remote patient monitoring, and wearable-integrated care solutions.
Major companies operating in the wearable and iomt medical devices market are Apple Inc., Samsung Electronics Co. Ltd., Huawei Technologies Co. Ltd., Abbott Laboratories, Xiaomi Corporation, Medtronic plc, Siemens Healthineers AG, Philips Healthcare, GE HealthCare Technologies Inc., Boston Scientific Corporation, Omron Healthcare Co. Ltd., Garmin Ltd., ResMed Inc., Dexcom Inc., Masimo Corporation, BIOTRONIK SE & Co. KG, iRhythm Technologies Inc., BioIntelliSense Inc., Valencell Inc., LifeSignals Inc., VitalConnect Inc., Intelesens Ltd., Sempulse Private Limited, Biobeat Technologies Ltd.
North America was the dominating region in the wearable and IoMT medical market in 2025. Asia-Pacific is expected to be the rapidly expanding region during the forecast period. The regions covered in the wearable and IoMT medical devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the wearable and IoMT medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The wearable and IoMT medical devices market consists of revenues earned by entities by providing services such as remote patient monitoring, real-time health data collection and analysis, device connectivity and integration, and digital health management through connected wearable and internet-enabled medical devices. The market value includes the value of related goods sold by the service provider or included within the service offering. The wearable and IoMT medical devices market also includes sales of wearable health monitoring devices, internet-enabled medical devices, connected biosensors, and smart diagnostic and monitoring equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Wearable and IoMT Medical Devices Market Characteristics
3. Wearable and IoMT Medical Devices Market Supply Chain Analysis
4. Global Wearable and IoMT Medical Devices Market Trends and Strategies
5. Wearable and IoMT Medical Devices Market Analysis of End Use Industries
7. Global Wearable and IoMT Medical Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Wearable and IoMT Medical Devices Total Addressable Market (TAM) Analysis for the Market
9. Wearable and IoMT Medical Devices Market Segmentation
10. Wearable and IoMT Medical Devices Market Regional and Country Analysis
11. Asia-Pacific Wearable and IoMT Medical Devices Market
12. China Wearable and IoMT Medical Devices Market
13. India Wearable and IoMT Medical Devices Market
14. Japan Wearable and IoMT Medical Devices Market
15. Australia Wearable and IoMT Medical Devices Market
16. Indonesia Wearable and IoMT Medical Devices Market
17. South Korea Wearable and IoMT Medical Devices Market
18. Taiwan Wearable and IoMT Medical Devices Market
19. South East Asia Wearable and IoMT Medical Devices Market
20. Western Europe Wearable and IoMT Medical Devices Market
21. UK Wearable and IoMT Medical Devices Market
22. Germany Wearable and IoMT Medical Devices Market
23. France Wearable and IoMT Medical Devices Market
24. Italy Wearable and IoMT Medical Devices Market
25. Spain Wearable and IoMT Medical Devices Market
26. Eastern Europe Wearable and IoMT Medical Devices Market
27. Russia Wearable and IoMT Medical Devices Market
28. North America Wearable and IoMT Medical Devices Market
29. USA Wearable and IoMT Medical Devices Market
30. Canada Wearable and IoMT Medical Devices Market
31. South America Wearable and IoMT Medical Devices Market
32. Brazil Wearable and IoMT Medical Devices Market
33. Middle East Wearable and IoMT Medical Devices Market
34. Africa Wearable and IoMT Medical Devices Market
36. Wearable and IoMT Medical Devices Market Competitive Landscape and Company Profiles
37. Wearable and IoMT Medical Devices Market Other Major and Innovative Companies
41. Wearable and IoMT Medical Devices Market High Potential Countries, Segments and Strategies
42. Appendix
Executive Summary
Wearable And IoMT Medical Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses wearable and iomt medical devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for wearable and iomt medical devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The wearable and iomt medical devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Wearable External Medical Devices; Implanted Medical Devices; Stationary Medical Devices; Other Types2) By Connectivity Technology: Bluetooth Or Bluetooth Low Energy; Wi Fi; Cellular; Zigbee; Other Connectivity Technologies
3) By Application: Patient Monitoring; Telemedicine; Medication Management; Other Applications
4) By End User: Healthcare Providers; Patients; Government Authorities; Other End Users
Subsegments:
1) By Wearable External Medical Devices: Smart Watches For Health Monitoring; Fitness And Activity Trackers; Wearable Blood Pressure Monitors; Wearable Glucose Monitors; Wearable Electrocardiogram Monitors2) By Implanted Medical Devices: Cardiac Pacemakers; Implantable Cardioverter Defibrillators; Neurostimulators; Cochlear Implants; Implantable Glucose Sensors
3) By Stationary Medical Devices: Hospital Bedside Monitors; Diagnostic Imaging Machines; Stationary Oxygen Concentrators; Dialysis Machines; Stationary Vital Sign Monitoring Systems
4) By Other Types: Smart Patches For Drug Delivery; Wearable Sleep Monitors; Portable Respiratory Devices; Continuous Temperature Monitors; Remote Patient Monitoring Hubs
Companies Mentioned: Apple Inc.; Samsung Electronics Co. Ltd.; Huawei Technologies Co. Ltd.; Abbott Laboratories; Xiaomi Corporation; Medtronic plc; Siemens Healthineers AG; Philips Healthcare; GE HealthCare Technologies Inc.; Boston Scientific Corporation; Omron Healthcare Co. Ltd.; Garmin Ltd.; ResMed Inc.; Dexcom Inc.; Masimo Corporation; BIOTRONIK SE & Co. KG; iRhythm Technologies Inc.; BioIntelliSense Inc.; Valencell Inc.; LifeSignals Inc.; VitalConnect Inc.; Intelesens Ltd.; Sempulse Private Limited; Biobeat Technologies Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Wearable and IoMT Medical Devices market report include:- Apple Inc.
- Samsung Electronics Co. Ltd.
- Huawei Technologies Co. Ltd.
- Abbott Laboratories
- Xiaomi Corporation
- Medtronic plc
- Siemens Healthineers AG
- Philips Healthcare
- GE HealthCare Technologies Inc.
- Boston Scientific Corporation
- Omron Healthcare Co. Ltd.
- Garmin Ltd.
- ResMed Inc.
- Dexcom Inc.
- Masimo Corporation
- BIOTRONIK SE & Co. KG
- iRhythm Technologies Inc.
- BioIntelliSense Inc.
- Valencell Inc.
- LifeSignals Inc.
- VitalConnect Inc.
- Intelesens Ltd.
- Sempulse Private Limited
- Biobeat Technologies Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | July 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 15.84 Billion |
| Forecasted Market Value ( USD | $ 26.8 Billion |
| Compound Annual Growth Rate | 14.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
